Concurrent mRNA and protein overexpressions were commonly observed for MET, including in CCRCC (RNA = 8%, PRO = 15%), CRC (RNA = 8%, PRO = 10%), and UCEC (RNA = 11%, PRO = 19%), where MET protein overexpressions were still detected in considerable cases without mRNA overexpression. Here, MET is linked to colorectal carcinoma.